Ken Griffin Rvl Pharmaceuticals PLC Transaction History

Citadel Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.56 - $1.17 $5,686 - $11,880	10,154 Added 24.44%	51,693 $28,000
Q1 2023 May 15, 2023	SELL	$1.02 - $1.39 $5,716 - $7,789	-5,604 Reduced 11.89%	41,539 $47,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $1.61 $26,093 - $41,187	25,582 Added 118.65%	47,143 $52,000
Q3 2022 Nov 14, 2022	BUY	$1.28 - $2.91 $27,598 - $62,742	21,561 New	21,561 $46,000
Q3 2020 Nov 16, 2020	SELL	$4.82 - $8.77 $71,721 - $130,497	-14,880 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.83 - $6.99 $127,188 - $314,151	-44,943 Reduced 75.13%	14,880 $100,000
Q1 2020 May 15, 2020	BUY	$3.18 - $7.0 $190,237 - $418,761	59,823 New	59,823 $190,000
Q4 2019 Feb 14, 2020	SELL	$3.46 - $7.7 $161,215 - $358,773	-46,594 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.8 - $3.99 $41,714 - $59,443	14,898 Added 47.0%	46,594 $178,000
Q2 2019 Aug 14, 2019	BUY	$2.34 - $4.28 $74,168 - $135,658	31,696 New	31,696 $120,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.